Outset Medical, Inc. Cash and Restricted Cash
Outset Medical, Inc. (OM) had Cash and Restricted Cash of $36.62 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2024-11-07
- 2024-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $36.62M.
- 2024-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $41.19M.
- 2024-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $35.51M.
- 2023-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $71.84M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2024-09-30 | $36.62M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $41.19M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $35.51M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $71.84M 10-K · filed 2024-02-21 |
| 2023-09-30 | $39.63M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $39.72M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $39.70M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $76.53M 10-K · filed 2024-02-21 |
| 2022-09-30 | $97.19M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $108.81M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $147.66M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $215.66M 10-K · filed 2024-02-21 |
| 2021-09-30 | $263.82M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $307.58M 10-Q · filed 2022-08-02 |
| 2021-03-31 | $285.08M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $328.28M 10-K · filed 2023-02-13 |
| 2020-09-30 | $344.64M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $145.88M 10-Q · filed 2021-08-06 |
| 2020-03-31 | $158.71M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $37.67M 10-K · filed 2022-02-23 |
| 2019-09-30 | $39.96M 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |